Answer
In previously seronegative children aged 12 months–2 years, one Priorix dose induced measles, mumps and rubella antibodies in 98.1%, 94.4% and 100%, respectively; two-year seroconversion rates were 93.4%, 94.4% and 100%, respectively, but protective efficacy data are unavailable and field studies suggest lower mumps effectiveness than seroconversion rates.
Sources for this answer
- Priorix powder and solvent for solution for injection in a pre-filled syringeGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 32Document updated
Sources checked